Filing Details

Accession Number:
0001596783-24-000052
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-30 16:53:51
Reporting Period:
2024-07-26
Accepted Time:
2024-07-30 16:53:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684270 Alessandro Maselli C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-07-26 98,671 $0.00 186,609 No 4 A Direct
Common Stock Disposition 2024-07-29 9,088 $58.76 177,521 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Restricted stock units (RSUs) received by the reporting person pursuant to the Issuers annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuers common stock as of the date of vesting, which will occur in three equal annual installments beginning on July 26, 2025.
  2. Includes RSUs.
  3. Shares sold by the reporting person through an automatic sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuers omnibus incentive plan. No shares were withheld by or surrendered to the Issuer.
  4. Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $58.67 to $58.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.